Citation: S. Retsas et C. Falkson, 2ND INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPY OF MALIGNANT-MELANOMA - LONDON, UK, 14-15 MARCH, 1997, Melanoma research, 7(2), 1997, pp. 153-155
Authors:
PHOTIOU A
SHAH P
LEONG LK
MOSS J
RETSAS S
Citation: A. Photiou et al., IN-VITRO SYNERGY OF PACLITAXEL (TAXOL) AND VINORELBINE (NAVELBINE) AGAINST HUMAN-MELANOMA CELL-LINES, European journal of cancer, 33(3), 1997, pp. 463-470
Citation: S. Retsas, SYSTEMIC TREATMENT OF MALIGNANT-MELANOMA - GRADE IS AS IMPORTANT AS STAGE, Clinical and experimental dermatology, 22(2), 1997, pp. 67-71
Citation: H. Mackenzie et S. Retsas, MALIGNANT-MELANOMA COEXISTING WITH SARCOIDOSIS - IMPLICATIONS FOR PROGNOSIS AND MANAGEMENT, Melanoma research, 6(1), 1996, pp. 71-72
Citation: A. Mohith et al., THE COMBINATION OF PACLITAXEL WITH CISPLATIN EXHIBITS ANTAGONISM IN-VITRO AGAINST HUMAN-MELANOMA, Anti-cancer drugs, 7(4), 1996, pp. 493-498
Citation: S. Retsas et al., TAXOL AND VINORELBINE - A NEW ACTIVE COMBINATION FOR DISSEMINATED MALIGNANT-MELANOMA, Anti-cancer drugs, 7(2), 1996, pp. 161-165
Citation: S. Retsas, STRATEGIES FOR IMPROVING SURVIVAL IN MALIGNANT-MELANOMA - FOCUS ON VINDESINE, Journal of drug development and clinical practice, 7(3), 1995, pp. 159-171
Citation: S. Retsas, 1ST INTERNATIONAL-CONFERENCE ON THE ADJUVANT THERAPY OF MALIGNANT-MELANOMA - LONDON, UK, 24-25 MARCH 1995, Melanoma research, 5(6), 1995, pp. 439-440
Citation: Mq. Mohammed et al., ACTIVITY OF PLATINUM DRUGS AGAINST MELANOMA CELL-LINES - IS IT MODULATED IN-VITRO IN THE PRESENCE OF TAMOXIFEN, Anticancer research, 15(4), 1995, pp. 1319-1326
Authors:
HOUGHTON PJ
PHOTIOU A
UDDIN S
SHAH P
BROWNING M
JACKSON SJ
RETSAS S
Citation: Pj. Houghton et al., ACTIVITY OF EXTRACTS OF KIGELIA-PINNATA AGAINST MELANOMA AND RENAL-CARCINOMA CELL-LINES, Planta medica, 60(5), 1994, pp. 430-433
Authors:
RETSAS S
QUIGLEY M
PECTASIDES D
MACRAE K
HENRY K
Citation: S. Retsas et al., CLINICAL AND HISTOLOGIC INVOLVEMENT OF REGIONAL LYMPH-NODES IN MALIGNANT-MELANOMA - ADJUVANT VINDESINE IMPROVES SURVIVAL, Cancer, 73(8), 1994, pp. 2119-2130
Citation: Aj. Stanley et al., EVALUATION OF S12363, A NOVEL VINCA ALKALOID DRUG IN THE TREATMENT OFADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY, Anticancer research, 13(1), 1993, pp. 31-32
Citation: C. Tolis et al., GROWTH INHIBITORY ACTIVITY OF S12363, A NOVEL VINCA ALKALOID DERIVATIVE ON HUMAN-MELANOMA CELL-LINES, Anticancer research, 13(1), 1993, pp. 161-166